| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/22/2000 | US6028079 Condensed-indan derivatives and pharmaceutically acceptable salts thereof |
| 02/22/2000 | US6028078 For trating cancer |
| 02/22/2000 | US6028077 For treating mammalian tumor selected from leukemia, lung carcinoma, colon carcinoma and melanoma by administering to said patient antitumor crambescidin compounds |
| 02/22/2000 | US6028075 Administering pharmaceutically effective amount of a compound for treatment of tumor sensitive to the compound |
| 02/22/2000 | US6028071 Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors |
| 02/22/2000 | US6028069 For treating or preventing arrhythmias, angina pectoris or infarcts comprising administering effective dosage to patient |
| 02/22/2000 | US6027927 Human trk receptors and neurotrophic factor inhibitors |
| 02/22/2000 | US6027924 Isolated nucleic acid molecule coding for tumor rejection antigen precursor MAGE-C1 and uses thereof |
| 02/22/2000 | US6027905 Methods for the detection of cervical cancer |
| 02/22/2000 | US6027878 A nucleic acid sequence; diagnosis of helicobacter infections, ulcers and gastrointestinal disorders |
| 02/22/2000 | US6027711 Structurally determined metallo-constructs and applications |
| 02/22/2000 | CA2004532C Peptide derivatives |
| 02/17/2000 | WO2000008495A2 Antiproliferative naphthoquinones, derivatives, compositions, and uses thereof |
| 02/17/2000 | WO2000008210A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 02/17/2000 | WO2000008206A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 02/17/2000 | WO2000008202A2 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | WO2000008191A2 Herpes virus vectors for dendritic cells |
| 02/17/2000 | WO2000008171A1 N-acetylglycosaminyl transferase genes |
| 02/17/2000 | WO2000008158A2 Molecules designated ldcam |
| 02/17/2000 | WO2000008150A1 Method for treatment of invasive cells |
| 02/17/2000 | WO2000008147A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 02/17/2000 | WO2000008144A1 Dna encoding a human inhibitor-of-apoptosis protein; hiap3 |
| 02/17/2000 | WO2000008141A2 Short oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | WO2000008140A2 Antisense oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | WO2000008139A1 Tumor necrosis factor-gamma |
| 02/17/2000 | WO2000008061A1 Reaction products of hyaluronic acid and natural amino acids and their use in cosmetic and pharmaceutical compositions |
| 02/17/2000 | WO2000008048A2 Inhibitor of histone deacetylase |
| 02/17/2000 | WO2000008033A1 Water soluble prodrugs of hindered alcohols or phenols |
| 02/17/2000 | WO2000008031A1 Novel phospholipids with unsaturated alkyl and acyl chains |
| 02/17/2000 | WO2000008024A1 Substituted imidazo[1,2a]azines as selective inhibotors of cox-2 |
| 02/17/2000 | WO2000008004A1 Particle-forming compositions containing fused pyrrolocarbazoles |
| 02/17/2000 | WO2000007996A2 Pyrazoles as estrogen receptor modulators |
| 02/17/2000 | WO2000007632A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/17/2000 | WO2000007619A1 Alteration of the cell cycle in vivo, and particularly for inducing apoptosis of tumor cells |
| 02/17/2000 | WO2000007616A2 Use of novel agents inducing cell death in synergy with interferons |
| 02/17/2000 | WO2000007609A1 Peptide antagonists of zonulin and methods for use of the same |
| 02/17/2000 | WO2000007607A1 Nutrient and therapeutic compositions for the treatment of cancer |
| 02/17/2000 | WO2000007605A1 Use of camptothecin derivatives, with reduced gastrointestinal toxicity |
| 02/17/2000 | WO2000007591A1 INDOLE sPLA2 INHIBITORS |
| 02/17/2000 | WO2000007581A2 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 02/17/2000 | WO2000007577A2 Phosphatidylcholine as a medicament for the protection of mucosa |
| 02/17/2000 | WO2000007576A2 INHIBITORS OF TYPE 3 3α-HYDROSTEROID DEHYDROGENASE |
| 02/17/2000 | WO2000007544A2 Vitronectin receptor antagonists |
| 02/17/2000 | WO2000007543A2 Conjugates targeted to the interleukin-2 receptors |
| 02/17/2000 | WO2000007515A1 Improved method for targeted topical treatment of disease |
| 02/17/2000 | WO2000000223A3 ANTIVIRAL AND ANTIRETROVIRAL RADIOIMMUNOMEDICAMENTS BASED ON α-EMITTERS AND β-EMITTERS |
| 02/17/2000 | WO1999065942A8 Cyclic somatostatin analogs |
| 02/17/2000 | WO1999063931A3 Peptidyl-prolyl cis-trans isomerase inhibitors and uses therefor |
| 02/17/2000 | WO1999055859A3 Cd40-interacting and traf-interacting proteins |
| 02/17/2000 | WO1999054310A3 New substituted amides, their production and their use |
| 02/17/2000 | WO1999053036A9 Ste20-related protein kinases |
| 02/17/2000 | WO1999050461A9 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 02/17/2000 | DE19836044A1 New 2-(hetero)aryl-alkanoic acid derivatives, useful as mixed endothelin receptor antagonists, e.g. for treating cardiac insufficiency, restenosis, hypertension or prostate cancer |
| 02/17/2000 | CA2383623A1 3-methylidenyl-2-indolinone modulators of protein kinase |
| 02/17/2000 | CA2348151A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/17/2000 | CA2347906A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 02/17/2000 | CA2347656A1 A novel method of diagnosing, monitoring, staging, imaging and treating lung cancer |
| 02/17/2000 | CA2340020A1 Use of camptothecin derivatives, with reduced gastrointestinal toxicity |
| 02/17/2000 | CA2339666A1 Vitronectin receptor antagonists |
| 02/17/2000 | CA2339473A1 Nutrient and therapeutic compositions for the treatment of cancer |
| 02/17/2000 | CA2339416A1 Short oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | CA2339413A1 Method for treatment of invasive cells |
| 02/17/2000 | CA2339368A1 Inhibitors of type 3 3.alpha.-hydroxysteroid dehydrogenase |
| 02/17/2000 | CA2339352A1 N-acetylglycosaminyltransferase genes |
| 02/17/2000 | CA2339340A1 Antisense oligonucleotides for the inhibition of vegf expression |
| 02/17/2000 | CA2339322A1 Genes involved in the molecular paths for tumour suppression and /or resistance to viruses |
| 02/17/2000 | CA2339187A1 Substituted imidazo¬1,2a|azines as selective inhibitors of cox-2 |
| 02/17/2000 | CA2339086A1 Dna replication- and repair-associated proteins |
| 02/17/2000 | CA2339085A1 Conjugates targeted to the interleukin-2 receptors |
| 02/17/2000 | CA2338727A1 Indole spla2 inhibitors |
| 02/17/2000 | CA2338385A1 Human receptor-associated proteins |
| 02/17/2000 | CA2338035A1 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid |
| 02/16/2000 | EP0979870A1 Human Wnt-6 polypeptide |
| 02/16/2000 | EP0979869A1 Short oligonucleotides for the inhibition of VEGF expression |
| 02/16/2000 | EP0979656A2 Composition containing radioisotopes immobilised on solid particles, and its use in brachytherapy |
| 02/16/2000 | EP0979513A1 PROCESS AND APPARATUS FOR THE PRODUCTION OF Bi-212 AND A USE THEREOF |
| 02/16/2000 | EP0979292A2 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
| 02/16/2000 | EP0979290A2 Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors |
| 02/16/2000 | EP0979289A1 Human lysophospholipase |
| 02/16/2000 | EP0979284A2 Methods and reagents for vaccination which generate a cd8 t cell immune response |
| 02/16/2000 | EP0979280A1 Polynucleotides encoding a cd53-like transmembrane protein |
| 02/16/2000 | EP0979275A1 Novel human mago nashi protein |
| 02/16/2000 | EP0979274A2 Human p24 vesicle proteins |
| 02/16/2000 | EP0979273A1 MODIFIED ANTISENSE NUCLEOTIDES COMPLEMENTARY TO A SECTION OF THE HUMAN Ha-Ras GENE |
| 02/16/2000 | EP0979246A2 Man monoclonal antibodies to epidermal growth factor receptor |
| 02/16/2000 | EP0979240A1 Serine protease inhibitors |
| 02/16/2000 | EP0979239A1 Prevention and treatment of hepatocellular cancer |
| 02/16/2000 | EP0979235A1 Isolated nucleic acid molecule coding for tumor rejection antigen precursors mage-c1 and mage-c2 and uses thereof |
| 02/16/2000 | EP0979104A1 Sonodynamic therapy using an ultrasound sensitizer compound |
| 02/16/2000 | EP0979103A1 Compounds |
| 02/16/2000 | EP0979102A1 Polyalkylene oxide-modified single chain polypeptides |
| 02/16/2000 | EP0979098A1 Method of treating hyperprolactinemia and prolactinomas |
| 02/16/2000 | EP0979093A1 Arrestable therapeutic viral agent |
| 02/16/2000 | CN1244921A Treatment and diagnosis of cancer |
| 02/16/2000 | CN1244873A Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 02/16/2000 | CN1244870A Tissue specific expression of retinoblastoma protein |
| 02/16/2000 | CN1244867A Substitued nitrogen containing heterocycles as inhibitors of P38 protein kinase |
| 02/16/2000 | CN1244799A L-beta-dioxolane uridine analogs and method for treating and preventing virus infections |
| 02/16/2000 | CN1244772A Targeted cytotoxic cell |
| 02/16/2000 | CN1244535A Preparation of Fenbijie general glycoside as a new anticarcinogen |